دورية أكاديمية

Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial

التفاصيل البيبلوغرافية
العنوان: Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial
المؤلفون: Altorki, Nasser K.Aff1, IDs41467023445753_cor1, Walsh, Zachary H., Melms, Johannes C., Port, Jeffery L., Lee, Benjamin E., Nasar, Abu, Spinelli, Cathy, Caprio, Lindsay, Rogava, Meri, Ho, Patricia, Christos, Paul J., Saxena, Ashish, Elemento, Olivier, Bhinder, Bhavneet, Ager, Casey, Amin, Amit Dipak, Sanfilippo, Nicholas J., Mittal, Vivek, Borczuk, Alain C., Formenti, Silvia C., Izar, BenjaminAff2, Aff8, Aff9, IDs41467023445753_cor21, McGraw, Timothy E.Aff10, IDs41467023445753_cor22
المصدر: Nature Communications. 15(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20411723
DOI:10.1038/s41467-023-44575-3